ArticleHistopathology2010

Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens.

Tomás García-Caballero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.